Isolagen^® is a biotechnology company 
     focused on developing emergent, novel
     skin and tissue rejuvenation
     technologies with broad potential in
     aesthetic and therapeutic markets.
 

June 19, 2009
Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion

June 16, 2009
Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code

May 8, 2009
Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review